SPONSOR
The First Affiliated Hospital of Nanchang University
Total Trials
4
Recruiting
4
Phases
Phase 2
NCT06751953
Recruiting
Neoantigen-loaded DC Vaccine and Conventional Third-line Therapy for CRC Progressed After Second-line Treatment
Colorectal Cancer (CRC)
NCT06751940
Recruiting
Neoantigen-loaded DC Vaccine and Conventional Second-line Therapy for CRC Progressed After First-line Treatment
Colorectal Cancer (CRC)
NCT06751901 Phase 2
Recruiting
Neoantigen-based Peptide Vaccine, PD-1 Inhibitor, and Radiotherapy for Advanced NSCLC Progressed After Second-line Treatment
Advanced NSCLC
NCT06751914
Recruiting
Neoantigen-based Peptide Vaccine and Conventional Second-line Therapy for CRC Progressed After First-line Treatment
Colorectal Cancer (CRC)